Thomas Bures
Director of Finance/CFO at PIERIS PHARMACEUTICALS, INC.
Net worth: 3 527 $ as of 31/03/2024
Profile
Thomas Bures is currently the Senior VP, Chief Financial & Accounting Officer at Pieris Pharmaceuticals, Inc. He previously worked as the Vice President & Assistant Controller at PAREXEL International Corp.
and as the Vice President & Controller at Genocea Biosciences, Inc. He obtained his undergraduate degree from the College of the Holy Cross (Massachusetts).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/04/2023 | 19,273 ( 0.02% ) | 3 527 $ | 31/03/2024 |
Thomas Bures active positions
| Companies | Position | Start |
|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 13/09/2019 |
Former positions of Thomas Bures
| Companies | Position | End |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01/12/2017 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Training of Thomas Bures
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
- Stock Market
- Insiders
- Thomas Bures
